End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2024-10-31
DOI
https://doi.org/10.3389/fonc.2024.1436587
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy

Delphine Demangel, Charles Dumontet, Anne Lazareth, Lionel Karlin et al.
Frontiers in Oncology
Multiple Myeloma Research and Treatments
article

End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy

Delphine Demangel, Charles Dumontet, Anne Lazareth, Lionel Karlin, Guillaume Aussedat, Emmanuel Bachy, Fadhéla Bouafia-Sauvy, Emmanuel Massy, Dana Ghergus, Alizée Maarek, Pierre Sesques, Hélène Lequeu, Hervé Ghesquières, Violaine Safar, Cyrille B. Confavreux, Emeline Perrial, Emmanuelle Ferrant, Camille Golfier
article en

Abstract

No abstract available for this paper.
Frontiers in OncologyVol. 14
Université Claude Bernard Lyon 1 (FR), Centre National de la Recherche Scientifique (FR), Inserm (FR), Hospices Civils de Lyon (FR), Hôpital Lyon Sud (FR), Centre de Recherche en Cancérologie de Lyon (FR)
Good health and well-being
Openalex Percentile: Top 68%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.